Euroelso Associates
- Country
- England & Wales
- Charity number
- 1153778
- Status
- Registered
- Registered
- Sept. 12, 2013
- Legal form
- Charitable company
- Area of benefit
- International
Address
- Address
- c/o Armstrong Watson
First Floor
1 Strawberry Lane
NEWCASTLE UPON TYNE
Contact
- Phone
- 01912328065
- [email protected]
- Website
euroelso.net
Activities
The objects of the charity are to advance and promote the relief of sickness across Europe through the development and evaluation of novel therapies for support of failing organ systems; maintaining a registry of such novel therapies; supporting clinical research and providing educational programs for medical professionals and lay communities including organising a scientific symposium each year.
Objects: To Advance Education, In Particular Among Scientists And Medical Professionals Throughout Europe, In Extra Corporeal Life Support Techniques For Failing Organ Systems In Particular By Providing Educational Programmes For Medical Professionals And By Promoting Research Into The Effects Of Such Techniques And To Publish The Useful Results For Public Benefit.
Classification
- How
- Provides Services, Sponsors Or Undertakes Research
- What
- Education/training, The Advancement Of Health Or Saving Of Lives
- Who
- The General Public/mankind
Areas of operation
- Country
- Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Liechtenstein, Luxembourg, Netherlands, Northern Ireland, Norway, Poland, Portugal, Romania, Scotland, Slovenia, Spain, Sweden, Switzerland
- Local Authority
- Newcastle Upon Tyne City
Finances
| Period end | Income | Expenditure |
|---|---|---|
| Nov. 30, 2024 | £139,226 | £76,603 |
| Nov. 30, 2023 | £42,258 | £116,182 |
| Nov. 30, 2022 | £57,395 | £130,186 |
| Nov. 30, 2021 | £21,700 | £62,706 |
| Nov. 30, 2020 | £170,609 | £50,968 |
Trustees
| Name | Appointed |
|---|---|
| Alain Combes | Feb. 11, 2019 |
| Jon Smith | April 29, 2013 |
| Simon Finney | Feb. 11, 2019 |
| Thomas Muller | Feb. 11, 2019 |